Clinical Trials Logo
  1. Home
  2. Cystitis, Interstitial
  3. NCT00380783

Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

Cystitis, Interstitial Clinical Trial

Clinical Trial Summary

This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with painful bladder syndrome/interstitial cystitis

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00380783
Study type Interventional
Source Allergan
Contact
Status Terminated
Phase Phase 2
Start date October 2006
Completion date March 2007
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT02868775 - A Study to Determine the Role of Toll-like Receptor-4 Expression in Patients With Interstitial Cystitis/Bladder Pain Syndrome N/A
Completed NCT00672087 - Diagnostic Challenges in IC (and Male CPPS)
Completed NCT01482676 - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction N/A
Completed NCT00775281 - Changes in Inflammatory and Contractile Protein Expression in Patients With Painful Bladder Syndrome/IC. N/A
Completed NCT05260112 - Smartphone-based Self-care Education Program for Women With Interstitial Cystitis: Educational Remote IC Aide N/A
Completed NCT05752344 - Interstitial Cystitis: Monitoring of the Psychic State and Counseling Intervention in the COVID-19 Era
Completed NCT01613586 - A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC) Phase 2
Completed NCT02411110 - A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome Phase 2
Recruiting NCT06299683 - Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment N/A
Completed NCT00248664 - Events Preceding Interstitial Cystitis (EPIC) N/A
Completed NCT00601484 - An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis Phase 2
Completed NCT02214550 - Chronic Pain Risk Associated With Menstrual Period Pain Phase 4
Completed NCT04275297 - Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome N/A
Terminated NCT00999518 - A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome Phase 2
Completed NCT00675298 - Linkage Analysis in Interstitial Cystitis N/A
Terminated NCT02781103 - Guided Imagery and Transcranial Direct Current Stimulation (tDCS) in Women With Chronic Pelvic Pain N/A
Recruiting NCT01074567 - DMSO Efficacy in IC/PBS Patients During and After Treatment N/A
Completed NCT02497976 - Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis Phase 3
Terminated NCT02787083 - A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis Phase 3
Withdrawn NCT00275379 - Study Evaluating Orally Administered ERB-041 in Subjects With Active Interstitial Cystitis N/A